BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35543077)

  • 21. [Heterochromia iridis, congenital deafness and skin pigmentary abnormalities: Waardenburg syndrome].
    Jiménez Gómez N; Ballester Martínez MA; Urrutia Hernando S; Jaén Olasolo P
    Med Clin (Barc); 2014 Mar; 142(6):e11. PubMed ID: 24029453
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hereditary hypomelanocytoses: the role of PAX3, SOX10, MITF, SNAI2, KIT, EDN3 and EDNRB genes].
    Otręba M; Miliński M; Buszman E; Wrześniok D; Beberok A
    Postepy Hig Med Dosw (Online); 2013 Nov; 67():1109-18. PubMed ID: 24379252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymmetric choroidal hypopigmentation in a Son and mother with Waardenburg syndrome type I.
    Grewal PS; Knight H; Michaelides M
    Ophthalmic Genet; 2020 Jun; 41(3):284-287. PubMed ID: 32281454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hearing loss and pigmentary disturbances in Waardenburg syndrome with reference to WS type II.
    Liu X; Newton V; Read A
    J Laryngol Otol; 1995 Feb; 109(2):96-100. PubMed ID: 7706933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular heterogeneity in two families with auditory pigmentary syndromes: the role of neuroimaging and genetic analysis in deafness.
    Shears D; Conlon H; Murakami T; Fukai K; Alles R; Trembath R; Bitner-Glindzicz M
    Clin Genet; 2004 May; 65(5):384-9. PubMed ID: 15099345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in inherited disorders of hypopigmentation: comparisons of mice and men.
    Bloom KE
    Curr Opin Pediatr; 1993 Aug; 5(4):458-63. PubMed ID: 8374674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hearing impairment and pigmentary disturbance.
    Beighton P; Ramesar R; Winship I; Viljoen D; Greenberg J; Young K; Curtis D; Sellars S
    Ann N Y Acad Sci; 1991; 630():152-66. PubMed ID: 1952586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical phenotype and genetic analysis of a Chinese pedigree affected with familial progressive hyperpigmentation and hypopigmentation].
    Xu Z; Su Z; Zheng R; Hou L; Zhang L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Dec; 39(12):1360-1365. PubMed ID: 36453959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical manifestations and novel pathogenic variants in SOX10 in eight Danish probands with Waardenburg syndrome.
    Moldenæs MF; Rendtorff ND; Hindbæk LS; Tørring PM; Nilssen Ø; Tranebjærg L
    Eur J Med Genet; 2021 Sep; 64(9):104265. PubMed ID: 34171448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel KIT mutation results in piebaldism with progressive depigmentation.
    Richards KA; Fukai K; Oiso N; Paller AS
    J Am Acad Dermatol; 2001 Feb; 44(2):288-92. PubMed ID: 11174389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial progressive hyperpigmentation and hypopigmentation without KITLG mutation.
    Zeng L; Zheng XD; Liu LH; Fu LY; Zuo XB; Chen G; Wang PG; Yang S; Zhang XJ
    Clin Exp Dermatol; 2016 Dec; 41(8):927-929. PubMed ID: 27859606
    [No Abstract]   [Full Text] [Related]  

  • 32. Piebaldism, Waardenburg syndrome, and related disorders of melanocyte development.
    Spritz RA
    Semin Cutan Med Surg; 1997 Mar; 16(1):15-23. PubMed ID: 9125761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Waardenburg Syndrome and the Management of Hearing Loss and Associated Sequelae: A Review for the Pediatric Nurse Practitioner.
    Ringer J
    J Pediatr Health Care; 2019; 33(6):694-701. PubMed ID: 31375308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype-phenotype correlations in type 1 Waardenburg syndrome.
    Lalwani AK; Mhatre AN; San Agustin TB; Wilcox ER
    Laryngoscope; 1996 Jul; 106(7):895-902. PubMed ID: 8667990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Piebaldism with deafness: molecular evidence for an expanded syndrome.
    Spritz RA; Beighton P
    Am J Med Genet; 1998 Jan; 75(1):101-3. PubMed ID: 9450866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism 1 in Japan.
    Tomita Y; Miyamura Y; Kono M; Nakamura R; Matsunaga J
    Pigment Cell Res; 2000; 13 Suppl 8():130-4. PubMed ID: 11041370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pigmentary mosaicism: a review of original literature and recommendations for future handling.
    Kromann AB; Ousager LB; Ali IKM; Aydemir N; Bygum A
    Orphanet J Rare Dis; 2018 Mar; 13(1):39. PubMed ID: 29506540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypomelanosis of ito-whorled hyperpigmentation combination: a mirror image presentation.
    Thapa R; Dhar S; Malakar R; Chakrabartty S
    Pediatr Dermatol; 2007; 24(5):572-3. PubMed ID: 17958820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical variability of Waardenburg-Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus.
    Tüysüz B; Collin A; Arapoğlu M; Suyugül N
    Am J Med Genet A; 2009 Oct; 149A(10):2290-5. PubMed ID: 19764031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutation of the EYA4 gene associated with post-lingual hearing loss in a proband is co-segregating with a novel PAX3 mutation in two congenitally deaf family members.
    Cesca F; Bettella E; Polli R; Cama E; Scimemi P; Santarelli R; Murgia A
    Int J Pediatr Otorhinolaryngol; 2018 Jan; 104():88-93. PubMed ID: 29287889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.